Skip to main content
Log in

Identification of vasopressor constituents of amniotic fluid in pregnancy toxaemia

  • Original Contributions
  • Published:
Ricerca in clinica e in laboratorio

Summary

The vasopressor activity of human amniotic fluid was assessed in 46 primigravidas during the third trimester of pregnancy. The subjects included 20 normal and 26 cases of pregnancy toxaemia. For identification of the vasoptessor activity of the amniotic fluid, blood pressure measurements were made in the intact rat, and the smooth muscle contraction of the rat ascending colon preparation was determinedin vitro. The samples of amniotic fluid showing vasoptessor activity were lyophilized and subjected to gel filtration using Sephadex G-100. The various fractions thus obtained were monitored at 280 nm and the pressor activity was re-estimated. It was observed that most of the pressor activity of the amniotic fluid of the toxaemic patients was capable of causing contraction of the rat colon as well as a significant rise in the systolic blood pressure of the intact rat. Furthermore, this activity was found to be heat-labile and was completely blocked by cinnarizine. Fractionation of the amniotic fluid showing vasopressor activity by gel filtration further substantiated the findings reported above. On the basis of these results it was concluded that the pressor activity of the amniotic fluid was due to the presence of an angiotensin II-like substance. Its concentration was found to be higher in the toxaemic group than in normotensive subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abraham O. L., Hawkins D. F.: Lipid-soluble uterine muscle stimulants in human amniotic fluid—J. Obstet. Gynaec. India74, 235, 1967.

    Google Scholar 

  2. Brown J. J., Davies D. L., Doak P. B., Lever A. F., Robertson J. I. S., Tree M.: The presence of renin in human amniotic fluid—Lancetii, 64, 1964.

    Article  Google Scholar 

  3. Carretero O. A., Bujak B., Hodari A. A., Hodgkinson C. P., Bumpus F. M.: Identification of a pressor polypeptide in human amniotic fluid—Amer. J. Obstet. Gynec.111, 1075, 1971.

    PubMed  CAS  Google Scholar 

  4. Ferraris F.: Sulia presenza nel liquido amniotico e nella placenta di una frazione lipidica ad azione attivante e regolarizzante la contrazione uterina e di una frazione lipidica inibente la contrazione stessa—Minerva ginec.10, 495, 1958.

    PubMed  CAS  Google Scholar 

  5. Gomel V., Hardwick D. F.: Search for a pressor substance in toxemia of pregnancy—Amer. J. Obstet. Gynec.94, 308, 1966.

    PubMed  CAS  Google Scholar 

  6. Gordon R. D., Parsons S., Symonds E. M.: A prospective study of plasma renin activity in normal and toxemic pregnancy—Lanceti, 347, 1969.

    Article  Google Scholar 

  7. Goretzlehner M. G., Riethling A. K.: The presence of a vascconstrictor substance in toxemia—Amer. J. Obstet. Gynec.101, 397, 1968.

    PubMed  CAS  Google Scholar 

  8. Hanon F., Zoquoin-Carnot M., Pignard P.: Le liquide amniotique. Masson et Cie, Paris, 1955; p. 144.

    Google Scholar 

  9. Hawkins D. F.: Oxytocic lipids in human amniotic fluid—Nature (Lond.)194, 975, 1962.

    Article  CAS  Google Scholar 

  10. Hunter C. A., Howard W. F. P.: A pressor substance in amnioric fluid—Amer. J. Obstet. Gynec.79, 838, 1960.

    PubMed  CAS  Google Scholar 

  11. Hunter C. A., Howard W. F. P.: Etiology of hypertension in toxemia of pregnancy—Amer. J. Obstet. Gynec.81, 441, 1961.

    PubMed  Google Scholar 

  12. Landesman R., Wilson K., La Russa R., Silverman F., Koide S.: Pressor polypeptides in amniotic fluid of normal and toxemic pregnancy—Obstet. and Gynec.24, 914, 1964.

    CAS  Google Scholar 

  13. Peart W. S.: A new method of large scale preparation of hypertensin with a note on its bioassay—Biochem. J.59, 300, 1955.

    PubMed  CAS  Google Scholar 

  14. Regoli D., Vane J. R.: A sensitive method for the assay of angiotensin—Brit. J. Pharmacol.23, 351, 1964.

    PubMed  CAS  Google Scholar 

  15. Skinner S. L., Cran E. J., Gibson R., Taylor R., Walters W. A. W., Catt K. J.: Angictensin I and II active and inactive and renin, renin substrate, tenin activity and angiotensinase in humanliquor amnii and plasma—Amer. J. Obstet. Gynec.121, 626, 1975.

    PubMed  CAS  Google Scholar 

  16. Tapia H. R., Johnson C. E., Strong C. G.: Renin-angiotensin system in normal and in hypertensive disease of pregnancy—Lancetii, 847, 1972.

    Article  Google Scholar 

  17. Weir R. J., Fraser R., Lever A. F., Morton J. J., Brown J. J., Kraszewski A., McIlwaine G. M., Robertson J. I. S., Tree M.: Plasma renin, renin substrate, angiotensin II and aldosterone in hypertensive disease of pregnancy—Lanceti, 291, 1973.

    Article  Google Scholar 

  18. Zuspan F. P., Abbott M.: Identification of a pressor substance in amniotic fluid—Amer. J. Obstet. Gynec.107, 664, 1970.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhall, K., Kumar, M., Dhall, G.I. et al. Identification of vasopressor constituents of amniotic fluid in pregnancy toxaemia. La Ricerca Clin. Lab. 9, 25–33 (1979). https://doi.org/10.1007/BF02905024

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02905024

Key-words

Navigation